JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.17% |
| 2 | Financials | 10.12% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 7.97% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHIL
3726
DELISTED
Diamond Hill
DHIL
| $2.91M | ﹤0.01% |
18,731
+7,469
| +66% | +$1.2M |
|
3727
TETRA Technologies
TTI
$1.27B
| $2.9M | ﹤0.01% |
810,581
+299,876
| +59% | +$1.07M |
|
3728
Daily Journal
DJCO
$831M
| $2.9M | ﹤0.01% |
5,099
+2,133
| +72% | +$1.14M |
|
3729
Beazer Homes USA
BZH
$872M
| $2.89M | ﹤0.01% |
105,306
+25,484
| +32% | +$814K |
|
3730
CALL
Lam Research
LRCX
$416B
| $2.89M | ﹤0.01% |
40,000
| – | – |
|
3731
Nuveen ESG Small-Cap ETF
NUSC
$1.35B
| $2.89M | ﹤0.01% |
68,885
-1,883
| -3% | -$82.2K |
|
3732
First Trust Global Tactical Commodity Strategy Fund
FTGC
$3.09B
| $2.88M | ﹤0.01% |
120,396
+43,646
| +57% | +$1.03M |
|
3733
PUT
Axsome Therapeutics
AXSM
$11.2B
| $2.88M | ﹤0.01% |
+34,000
| New | +$3.13M |
|
3734
Castle Biosciences
CSTL
$905M
| $2.88M | ﹤0.01% |
107,936
+38,527
| +56% | +$1.17M |
|
3735
CALL
Fastenal
FAST
$58.5B
| $2.88M | ﹤0.01% |
80,000
| – | – |
|
|
3736
PUT
Fastenal
FAST
$58.5B
| $2.88M | ﹤0.01% |
80,000
| – | – |
|
3737
Quanterix
QTRX
$122M
| $2.87M | ﹤0.01% |
270,054
+52,097
| +24% | +$634K |
|
3738
Cerence
CRNC
$407M
| $2.87M | ﹤0.01% |
365,594
-25,949
| -7% | -$130K |
|
3739
Dimensional Global Core Plus Fixed Income ETF
DFGP
$3.46B
| $2.87M | ﹤0.01% |
54,293
+2,491
| +5% | +$135K |
|
3740
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.39B
| $2.87M | ﹤0.01% |
19,891
+80
| +0.4% | +$11.4K |
|
|
FPI
3741
Farmland Partners
FPI
$433M
| $2.86M | ﹤0.01% |
243,045
+117,350
| +93% | +$1.38M |
|
3742
Reynolds Consumer Products
REYN
$5.53B
| $2.86M | ﹤0.01% |
105,827
-93,160
| -47% | -$2.64M |
|
3743
CALL
McKesson
MCK
$101B
| $2.85M | ﹤0.01% |
5,000
| – | – |
|
3744
Columbus McKinnon
CMCO
$556M
| $2.85M | ﹤0.01% |
76,512
+49,498
| +183% | +$1.8M |
|
3745
ADT
ADT
$5.47B
| $2.84M | ﹤0.01% |
410,814
-73,955
| -15% | -$539K |
|
3746
Invesco Aerospace & Defense ETF
PPA
$8.77B
| $2.84M | ﹤0.01% |
24,741
+8,523
| +53% | +$1.01M |
|
|
DHC
3747
Diversified Healthcare Trust
DHC
$2.03B
| $2.84M | ﹤0.01% |
1,233,790
+369,984
| +43% | +$1.09M |
|
3748
PDF Solutions
PDFS
$2.15B
| $2.83M | ﹤0.01% |
104,627
+30,552
| +41% | +$921K |
|
3749
UFP Technologies
UFPT
$2.49B
| $2.83M | ﹤0.01% |
11,573
+525
| +5% | +$153K |
|
3750
Shinhan Financial Group
SHG
$35.4B
| $2.83M | ﹤0.01% |
85,999
+81,553
| +1,834% | +$3.15M |
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.